Skip to main content

Yamin Li

FY2026 NIH rank #13,222
  • Early Career
  • Diverse Portfolio

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 15959924Search this ID in NIH RePORTER
ORCID iD
No ORCID iD on recordA researcher can add one by claiming this profile.
ScienceDex PI coverage
FY2025 through FY2026Career claims are limited to the years shown.

FY2026 award categories

  • Pharmacology

NIH Funding · FY2026

Linked Award Amount
$1.5M
Full award amounts, FY2026
Award Records
4
Records listing this PI
Award-Linked Rank
#13,222
By linked amount among FY2026 PIs
Earliest Year Loaded
2025
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Yamin Li. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2026 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2026 award records by amount

NIH award records listing Yamin Li as a PI. Multi-PI records show the full award amount for context.

  • 1R21HL184087-01R21
    Lung-targeting immunomodulatory mRNA-lipid nanoparticle system
    $448.3K
    award amount
  • 5R35GM160083-02R35
    Developing sulfonium lipid nanoparticles as a novel platform for mRNA delivery
    $448.3K
    award amount
  • 1R41HL184801-01A1R41
    A Lung-Specific, Sulfonium Lipid Nanoparticle (sLNP) Formulation of Incyclinide for the Treatment of ALI/ARDS
    $368K
    award amount
  • 1R21EB040117-01R21
    mRNA/Lipid nanoparticle-mediated genome editing in the brain.
    $244.5K
    award amount

Award organizations

Organizations that administered FY2026 awards listing Yamin Li as a PI.

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2025
    First NIH Award
    SUNY Upstate Medical University
  2. 2026
    $500K Cumulative Funding
  3. 2026
    $1M Cumulative Funding
  4. 2026
    Multi-Institutional Research
    Awards at 2 institutions

Shared-award investigators

Other investigators listed on at least one of the same NIH award records as Yamin Li.